Aria Pharmaceuticals – Medium

Aria Pharmaceuticals

More Progress, with More Confidence

By: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals

Dec 19, 2022

Dec 19, 2022

We Must Unblock the Sharing of Data

By: Aaron C. Daugherty, VP of Discovery, Aria Pharmaceuticals

Nov 9, 2022

Nov 9, 2022

Moving the dialogue forward: The need for better AI integration in drug discovery

By: Andrew A Radin, CEO & Co-founder, Aria Pharmaceuticals

Mar 16, 2022

Moving the dialogue forward: The need for better AI integration in drug discovery

Mar 16, 2022

A Transformational Year for Aria

By: Andrew A Radin

Dec 14, 2021

A Transformational Year for Aria

Dec 14, 2021

A New Era of Hope for Idiopathic Pulmonary Fibrosis

By: Anjali Pandey, Ph.D.

Sep 30, 2021

A New Era of Hope for Idiopathic Pulmonary Fibrosis

Sep 30, 2021

What’s In A Name? Artistry and Sound Science!

By: Andrew A. Radin

May 26, 2021

What’s In A Name? Artistry and Sound Science!

May 26, 2021

R&D Is Changing And I’m On Board

by: Mark Eller, Ph.D. SVP of R&D, twoXAR

Mar 31, 2021

R&D Is Changing And I’m On Board

Mar 31, 2021

This Year’s JPM Healthcare Conference Should Give Our Industry Confidence

Andrew A. Radin CEO, twoXAR Pharmaceuticals

Jan 21, 2021

This Year’s JPM Healthcare Conference Should Give Our Industry Confidence

Jan 21, 2021

Looking forward to 2021 at twoXAR

Andrew A. Radin CEO, twoXAR Pharmaceuticals

Dec 16, 2020

Looking forward to 2021 at twoXAR

Dec 16, 2020

Why twoXAR Pharmaceuticals isn’t working on COVID-19

by: Andrew A. Radin CEO, twoXAR

Oct 28, 2020

Why twoXAR Pharmaceuticals isn’t working on COVID-19

Oct 28, 2020

Aria Pharmaceuticals

Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex diseases.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Rules
Terms
Text to speech